Ann Livingstone

Livingstone Cropped  

Ann Livingstone is a PhD candidate at the NHMRC Clinical Trials Centre, University of Sydney. Ann completed a Master of Health Service Management, University of Technology Sydney, more recently obtaining a Graduate Diploma in Health Economics and Policy at Monash University, Melbourne.  She possesses over 15 years of clinical research experience. Ann's PhD topic will investigate the trade-offs patients with melanoma are willing to make for treatment.


Connect with Ann


Patients with stage 3 melanoma considering adjuvant immunotherapy value survival over potential treatment harms i.e. toxicity.

Little is known about patients with stage 3 melanoma treatment preferences for adjuvant immunotherapy, or the factors patients consider important when making adjuvant immunotherapy decisions. 

Click to view full size image

 ALivingstone VP